Wright et al., using 16 cell lines from distinct BRCA1 deficient mouse mammary tumours , found that these tumours harbor heterogeneous CSC populations and that CD44+/ CD24- cells represent a population that correlates with human breast CSCs (18). This evidence concerns the gene CD44 and breast cancer.